Get the Stockscreener App
102.71
1.56%
-1.63
Boston Scientific Corp stock is traded at $102.71, with a volume of 10.54M.
It is down -1.56% in the last 24 hours and up +0.07% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$104.34
Open:
$103.76
24h Volume:
10.54M
Relative Volume:
1.51
Market Cap:
$152.19B
Revenue:
$18.49B
Net Income/Loss:
$2.50B
P/E Ratio:
61.14
EPS:
1.68
Net Cash Flow:
$3.49B
1W Performance:
-4.21%
1M Performance:
+0.07%
6M Performance:
+6.52%
1Y Performance:
+22.52%
1-Day Range:
$102.48
$104.43
1-Week Range:
$102.48
$109.50
52-Week Range:
$80.64
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Strs Ohio Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Focus Partners Wealth Decreases Holdings in Boston Scientific Corporation $BSX - MarketBeat
26,545 Shares in Boston Scientific Corporation $BSX Acquired by Integrity Alliance LLC. - MarketBeat
Boston Scientific Corporation $BSX Stock Position Increased by NewEdge Advisors LLC - MarketBeat
Reliant Investment Partners LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Intech Investment Management LLC - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Woodline Partners LP - MarketBeat
Empowered Funds LLC Has $9.16 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
MBB Public Markets I LLC Invests $316,000 in Boston Scientific Corporation $BSX - MarketBeat
Axiom Investors LLC DE Purchases 1,006,828 Shares of Boston Scientific Corporation $BSX - MarketBeat
Sandler Capital Management Has $4.22 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Nissay Asset Management Corp Japan ADV Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Q1 EPS Forecast for Boston Scientific Raised by Analyst - Defense World
Boston Scientific Corporation $BSX Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - MarketBeat
Boston Scientific Corporation $BSX is Parkman Healthcare Partners LLC's 10th Largest Position - MarketBeat
Clark Capital Management Group Inc. Raises Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific issues follow-up notice on Accolade pacemaker software update - MassDevice
Boston Scientific (NYSE:BSX) Reaches New 12-Month High After Analyst Upgrade - MarketBeat
Boston Scientific (BSX): Examining Valuation Following Leadership Change and FARAPULSE FDA Rollout - Yahoo Finance
Zurich Insurance Group Ltd FI Sells 381,406 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific stock rating reiterated at Buy by Needham - Investing.com
Elutia to divest bioenvelopes business to Boston Scientific for $88m - Yahoo Finance
Boston Scientific warns of tariff impact as it reports Irish profit - Business Post
Leerink Partnrs Has Bullish Forecast for BSX Q2 Earnings - Defense World
Edmond DE Rothschild Holding S.A. Sells 40,906 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know - Yahoo Finance
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Great Lakes Advisors LLC Has $208.80 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Boston Scientific inks $88M Elutia deal to challenge Medtronic - MedTech Dive
Ascent Group LLC Has $5.04 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Oppenheimer Upgrades Boston Scientific (NYSE:BSX) to "Outperform" - MarketBeat
Meiji Yasuda Asset Management Co Ltd. Has $9.35 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Voleon Capital Management LP Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Fred Alger Management LLC Sells 397,418 Shares of Boston Scientific Corporation $BSX - MarketBeat
Dynamic Technology Lab Private Ltd Makes New $1.10 Million Investment in Boston Scientific Corporation $BSX - MarketBeat
Eventide Asset Management LLC Has $3.23 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (NYSE:BSX) Hits New 12-Month High on Analyst Upgrade - Defense World
Cinctive Capital Management LP Invests $10.45 Million in Boston Scientific Corporation $BSX - MarketBeat
EP Wealth Advisors LLC Buys 16,149 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Sci acquires Elutia's bioenvelopes for $88M - BioWorld MedTech
DnB Asset Management AS Purchases 15,256 Shares of Boston Scientific Corporation $BSX - MarketBeat
Gaithersburg’s Elutia selling key business line to Boston Scientific, sets sights on new products - The Business Journals
Boston Scientific stock hits all-time high at 109.15 USD By Investing.com - Investing.com Nigeria
Boston Scientific stock hits all-time high at 109.15 USD - Investing.com
Boston Scientific to Buy Elutia’s BioEnvelope Biz for $88M - Medical Product Outsourcing
Elutia to sell bioenvelope products to Boston Scientific for $88 million - Investing.com
Did Boston Scientific's (BSX) Executive Change Signal a New Chapter for Peripheral Interventions Leadership? - Yahoo Finance
Elutia Inc. Sells BioEnvelope Business to Boston Scientific for $88 Million to Fund NXT-41 Development - Quiver Quantitative
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million - Yahoo Finance
Boston Scientific Corporation $BSX is Stance Capital LLC's 10th Largest Position - MarketBeat
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):